Whitehawk Therapeutics, Inc.

NasdaqCM:WHWK Stock Report

Market Cap: US$233.3m

Whitehawk Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:WHWK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 May 26BuyUS$8,930,975Acuta Capital Partners, LLCCompany2,278,310US$3.92
16 Apr 26SellUS$882,028Scott GiacobelloIndividual218,600US$4.13
14 Apr 26SellUS$427,860Bryan BallIndividual118,849US$3.64
10 Apr 26SellUS$201,124Bryan BallIndividual56,596US$3.57
09 Apr 26SellUS$49,010David LennonIndividual14,500US$3.38
08 Apr 26SellUS$899,538David LennonIndividual260,427US$3.51

Insider Trading Volume

Insider Buying: WHWK insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of WHWK?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders4,792,1779.7%
General Public5,620,21111.4%
VC/PE Firms7,053,93914.3%
Institutions12,669,26225.6%
Hedge Funds19,292,58839%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 83.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.48%
Acuta Capital Partners, LLC
4,685,912US$22.1m37.4%17.51%
9.34%
QVT Financial LP
4,615,709US$21.8m0%1.56%
8.43%
OrbiMed Advisors LLC
4,166,000US$19.7m0%0.31%
7.49%
Suvretta Capital Management, LLC
3,700,000US$17.5m0%0.42%
7.02%
Avoro Capital Advisors LLC
3,471,752US$16.4m21.8%0.18%
5.84%
Ally Bridge Group
2,887,939US$13.6m-0.91%5.54%
5.7%
Coastlands Capital LP
2,819,215US$13.3m0%no data
4.38%
Kvp Capital Advisors, LP
2,165,998US$10.2m0%8.79%
4.21%
Artal Group S.A.
2,082,000US$9.8m0%0.17%
3.66%
Neil Desai
1,811,241US$8.5m0%no data
2.66%
Vanguard Capital Management, LLC
1,315,770US$6.2m0%no data
2.53%
Baiteng Zhao
1,250,000US$5.9m0%no data
2.31%
Acorn Bioventures
1,139,363US$5.4m0%1.77%
1.9%
StemPoint Capital LP
939,369US$4.4m-35.6%0.8%
1.15%
David Lennon
569,643US$2.7m1,180%no data
1.11%
Balyasny Asset Management L.P.
550,441US$2.6m0%0.01%
0.93%
Geode Capital Management, LLC
457,540US$2.2m7.55%no data
0.91%
Bryan Ball
448,126US$2.1m118%no data
0.87%
Renaissance Technologies LLC
428,622US$2.0m-2.75%no data
0.71%
BlackRock, Inc.
351,385US$1.7m17.5%no data
0.68%
Braden Leonard
335,000US$1.6m0%no data
0.67%
Scott Giacobello
333,489US$1.6m1,090%no data
0.63%
Millennium Management LLC
309,674US$1.5m0%no data
0.62%
Eversept Partners, L.P.
306,800US$1.4m17.9%0.1%
0.57%
Woodline Partners LP
281,497US$1.3m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/31 01:30
End of Day Share Price 2026/05/29 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Whitehawk Therapeutics, Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Reni BenjaminCitizens JMP Securities, LLC
Robert BurnsH.C. Wainwright & Co.
Roger SongJefferies LLC